MEDNAX, Inc. (MD) Tops Q3 EPS by 1c

MEDNAX, Inc. (NYSE: MD) reported Q3 EPS of $0.86, $0.01 better than the analyst estimate of $0.85. Revenue for the quarter came in at $627 million versus the consensus estimate of $619.61 million.

MEDNAX, Inc. sees Q4 2014 EPS of $0.83-$0.87, versus the consensus of $0.88.

For earnings history and earnings-related data on MEDNAX, Inc. (MD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
• Infleqtion raises Q2 revenue to $13.5M after contract restatement